Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
June 5, 2019
Oncolytics Biotech (R) Announces Study to Investigate Combination of Pelareorep and Avelumab in Metastatic Breast Cancer in Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / June 5, 2019 / Oncolytics Biotech® Inc. (ONCY) (ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic ...
June 5, 2019
InflaRx Announces Top-Line SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa
JENA, Germany, June 05, 2019 (GLOBE NEWSWIRE) -- InflaRx (IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics targeting the complement system, today reported the top-line ...
June 5, 2019
Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development
PALO ALTO, Calif., June 5, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of therapies for rare diseases, announced today the ...
June 5, 2019
Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs
GAITHERSBURG, Md., June 05, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage biotechnology company, today announced that it has received additional patent protection for ...
June 5, 2019
CohBar to Hold 2019 Annual Shareholder Meeting and Investor Update June 18, 2019
MENLO PARK, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR) a clinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases ...
June 5, 2019
Chiasma Strengthens Leadership Team Ahead of Anticipated Commercial Availability of Mycapssa®
WALTHAM, Mass., June 05, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and ...
June 5, 2019
Pfenex to Participate at the JMP Securities Life Sciences Conference
SAN DIEGO, June 05, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex ...
June 4, 2019
Orchard Therapeutics Launches Proposed Public Offering
BOSTON and LONDON, June 03, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with ...
June 4, 2019
VBL Therapeutics to Provide Additional Details on the New VB-111 Data Presented Earlier This Week at ASCO, in a Presentation at the 2019 BIO International Convention Today
TEL AVIV, Israel, June 04, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), announced that Dr. Dror Harats, CEO will deliver a company presentation today at ...
June 4, 2019
Sorrento Announces Cannabidiol (CBD) Global Joint Ventures and Commercial Strategic Partnerships
SAN DIEGO, June 04, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Sorrento, Nasdaq: SRNE) announces that it has formed a Chinese joint venture, Shenzhen Yunma ...
June 4, 2019
NexoBrid® Receives Marketing Authorization from Peru’s Ministry of Health
YAVNE, Israel, June 04, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
June 4, 2019
Foamix Announces Publication of Phase 3 FMX101 Acne Study in Journal of American Academy of Dermatology
REHOVOT, Israel and BRIDGEWATER, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical-stage pharmaceutical company that specializes in developing and commercializing proprietary topical therapies ...
June 4, 2019
Actinium Presents New Pivotal Phase 3 SIERRA Trial Data Showing Rapid Peripheral Blast Reduction and Anti-Leukemic Effect with Single Agent Iomab-B in Older Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia at 2019 ASCO Annual Meeting
NEW YORK, June 4, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") presented new data from the ongoing pivotal Phase 3 SIERRA study of ...
June 4, 2019
AIT Therapeutics Announces $8 Million PIPE Financing
GARDEN CITY, N.Y. and REHOVOT, Israel, June 04, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on ...
June 4, 2019
Theravance Biopharma Appoints Andrew Hindman as Senior Vice President and Chief Financial Officer
DUBLIN, June 4, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma" or the "Company") today announced the appointment of Andrew Hindman as Senior Vice President ...
June 4, 2019
Zealand Pharma to attend Citi European Healthcare Conference
Copenhagen, June 4, 2019 – Zealand Pharma Chief Executive Officer Emmanuel Dulac and Chief Medical and Development Officer Adam Steensberg will attend the Citi 8th ...
June 4, 2019
Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders and Provides Update on Neovasc Reducer™
VANCOUVER, June 4, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters ...
May 16, 2019
Sierra to Present SRA737 Preliminary Clinical Data and Potential Next Steps at ASCO
VANCOUVER, May 15, 2019 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of ...
May 16, 2019
Y-mAbs Announces Data to be Presented at 2019 ASCO Annual Meeting
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc., (the “Company” or “Y-mAbs”) (YMAB) a late-stage clinical biopharmaceutical company focused on the development ...
May 16, 2019
Oncolytics Biotech (R) Publishes Abstract Highlighting Additional Biomarker Analyses at the 2019 American Society of Clinical Oncology Annual Meeting
CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE / May 16, 2019 / Oncolytics Biotech® Inc. (ONCY) (ONC.TO), currently developing pelareorep, an intravenously delivered immuno-oncolytic ...
Page 13 of 158